| This article has been cited by |
| 1 | Pharmacology, Part 4: Nuclear Cardiology | |
| Geoffrey M. Currie |
| Journal of Nuclear Medicine Technology.2019;47(2)97 |
| [DOI] |
|
| 2 | Regadenoson Stress Testing: A Comprehensive Review With a Focused Update | |
| Karim O Elkholy,Omar Hegazy,Adeniyi Okunade,Suat Aktas,Temitope Ajibawo |
| Cureus.2021;47(2)97 |
| [DOI] |
|
| 3 | Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors | |
| David S. Hong,Patricia LoRusso,Omid Hamid,Filip Janku,Muaiad Kittaneh,Daniel V.T. Catenacci,Emily Chan,Tanios Bekaii-Saab,Shirish M. Gadgeel,Robert D. Loberg,Benny M. Amore,Yuying C. Hwang,Rui Tang,Gataree Ngarmchamnanrith,Eunice L. Kwak |
| Clinical Cancer Research.2019;25(8)2403 |
| [DOI] |
|
| 4 | Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging | |
| Sohab S. Radwan,Owen G. Schwartz |
| Case Reports in Cardiology.2019;2019(8)1 |
| [DOI] |
|
| 5 | Pharmacological Activity and Clinical Use of PDRN | |
| Francesco Squadrito,Alessandra Bitto,Natasha Irrera,Gabriele Pizzino,Giovanni Pallio,Letteria Minutoli,Domenica Altavilla |
| Frontiers in Pharmacology.2017;8(8)1 |
| [DOI] |
|
| 6 | Adenosine A2A Receptor Activation Enhances Blood–Tumor Barrier Permeability in a Rodent Glioma Model | |
| Amélie Vézina,Monica Manglani,DreeAnna Morris,Brandon Foster,Matthew McCord,Hua Song,Meili Zhang,Dionne Davis,Wei Zhang,Jessica Bills,Kunio Nagashima,Priya Shankarappa,Jessica Kindrick,Stuart Walbridge,Cody J. Peer,William D. Figg,Mark R. Gilbert,Dorian B. McGavern,Leslie L. Muldoon,Sadhana Jackson |
| Molecular Cancer Research.2021;19(12)2081 |
| [DOI] |
|
| 7 | Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma | |
| Carlos Salgado Garcia,Amelia Jimenez Heffernan,Elena Sanchez de Mora,Carlos Ramos Font,Juana Lopez Martin,Francisco Rivera de los Santos,Ignacio Ynfante Milá |
| European Journal of Nuclear Medicine and Molecular Imaging.2014;41(1)119 |
| [DOI] |
|
| 8 | Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole | |
| Michelle Friedman,James Spalding,Smita Kothari,You Wu,Elyse Gatt,Luke Boulanger |
| Journal of Medical Economics.2013;16(4)449 |
| [DOI] |
|
| 9 | When to re-dose regadenoson? | |
| Gregory S. Thomas,Aaron F. Jolly,Michael Safani |
| Journal of Nuclear Cardiology.2017;24(1)66 |
| [DOI] |
|
| 10 | A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors† | |
| Hirofumi Yasui,Ning Go,Hui Yang,Benny M. Amore,A. Scott Jung,Toshihiko Doi |
| Japanese Journal of Clinical Oncology.2017;47(8)772 |
| [DOI] |
|
